BBC·3 min read·medium
New weight loss pill approved for use in UK
✦AI Summary
The UK has become the first European country to approve 'Foundayo,' a daily weight-loss pill developed by Eli Lilly for obesity and type 2 diabetes. While currently available for private purchase, the drug's potential for NHS use is still under review.
Share Save Add as preferred on Google Nick Triggle Health correspondent Getty Images A daily weight-loss pill made by the drug firm behind the Mounjaro jab has been approved for use in the UK - the first country in Europe to do so.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in